Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts

Journal of Immunology

Volumn 188, Issue 9, 2012, Pages 4701-4708

  Gertner Dardenne, Julie ^a,b   Castellano, Remy ^c   Mamessier, Emilie ^a,d   Garbit, Slaveia ^c   Kochbati, Eloïse ^a   Etienne, Anne ^a   Charbonnier, Aude ^a   Collette, Yves ^c   Vey, Norbert ^a   Olive, Daniel ^a,b  

^a INSTITUT PAOLI CALMETTES   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c INSERM   (France)

^d CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GRANZYME; PERFORIN; T LYMPHOCYTE RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOTRANSPLANTATION; BLAST CELL; CANCER CONTROL; CANCER INHIBITION; CELL EXPANSION; CELL KILLING; CELL SELECTION; CELL SPECIFICITY; CELL SURVIVAL; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; EFFECTOR CELL; EX VIVO STUDY; FEMALE; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; LYMPHOCYTE HOMING; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR ENGRAFTMENT; XENOTRANSPLANTATION;

ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BLAST CRISIS; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; GRANZYMES; HUMANS; IMMUNOLOGIC MEMORY; LEUKEMIA, MYELOID, ACUTE; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PERFORIN; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS;

EID: 84860347848     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103710     Document Type: Article

References (46)

1. Butturini, A., M. M. Bortin, and R. P. Gale. 1987. Graft-versus-leukemia following bone marrow transplantation. Bone Marrow Transplant. 2: 233-242.
2. Horowitz, M. M., R. P. Gale, P. M. Sondel, J. M. Goldman, J. Kersey, H. J. Kolb, A. A. Rimm, O. Ringdén, C. Rozman, B. Speck, et al. 1990. Graft-versusleukemia reactions after bone marrow transplantation. Blood 75: 555-562. (Pubitemid 20069191)
3. Van Driessche, A., L. Gao, H. J. Stauss, P. Ponsaerts, D. R. Van Bockstaele, Z. N. Berneman, and V. F. Van Tendeloo. 2005. Antigen-specific cellular immunotherapy of leukemia. Leukemia 19: 1863-1871. (Pubitemid 41553993)
4. Vago, L., S. K. Perna, M. Zanussi, B. Mazzi, C. Barlassina, M. T. Stanghellini, N. F. Perrelli, C. Cosentino, F. Torri, A. Angius, et al. 2009. Loss of mismatched HLA in leukemia after stem-cell transplantation. N. Engl. J. Med. 361: 478-488.
5. van der Veken, L. T., R. S. Hagedoorn, M. M. van Loenen, R. Willemze, J. H. Falkenburg, and M. H. Heemskerk. 2006. ab T-cell receptor engineered gd T cells mediate effective antileukemic reactivity. Cancer Res. 66: 3331-3337.
6. Watanabe, N., M. Narita, A. Yokoyama, A. Sekiguchi, A. Saito, N. Tochiki, T. Furukawa, K. Toba, Y. Aizawa, and M. Takahashi. 2006. Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gd T cells expanded from peripheral blood cells by stimulation with zoledronate. Cytotherapy 8: 118-129. (Pubitemid 43675198)
7. Meeh, P. F., M. King, R. L. O'Brien, S. Muga, P. Buckhalts, R. Neuberg, and L. S. Lamb, Jr. 2006. Characterization of the gd T cell response to acute leukemia. Cancer Immunol. Immunother. 55: 1072-1080. (Pubitemid 43800722)
8. D'Asaro, M., C. La Mendola, D. Di Liberto, V. Orlando, M. Todaro, M. Spina, G. Guggino, S. Meraviglia, N. Caccamo, A. Messina, et al. 2010. Vγ9Vδ2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinibsensitive, and imatinib-resistant chronic myelogenous leukemia cells. J. Immunol. 184: 3260-3268.
9. + leukemia model. PLoS ONE 6: e16700.
10. Constant, P., F. Davodeau, M. A. Peyrat, Y. Poquet, G. Puzo, M. Bonneville, and J. J. Fournié. 1994. Stimulation of human gd T cells by nonpeptidic mycobacterial ligands. Science 264: 267-270.
11. Halary, F., M. A. Peyrat, E. Champagne, M. Lopez-Botet, A. Moretta, L. Moretta, H. Vié, J. J. Fournié, and M. Bonneville. 1997. Control of self-reactive cytotoxic T lymphocytes expressing gd T cell receptors by natural killer inhibitory receptors. Eur. J. Immunol. 27: 2812-2821. (Pubitemid 27478348)
12. Morita, C. T., E. M. Beckman, J. F. Bukowski, Y. Tanaka, H. Band, B. R. Bloom, D. E. Golan, and M. B. Brenner. 1995. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gd T cells. Immunity 3: 495-507.
13. Gober, H. J., M. Kistowska, L. Angman, P. Jenö, L. Mori, and G. De Libero. 2003. Human T cell receptor gd cells recognize endogenous mevalonate metabolites in tumor cells. J. Exp. Med. 197: 163-168. (Pubitemid 36152311)
14. Ensslin, A. S., and B. Formby. 1991. Comparison of cytolytic and proliferative activities of human gd and ab T cells from peripheral blood against various human tumor cell lines. J. Natl. Cancer Inst. 83: 1564-1569.
15. Boismenu, R., and W. L. Havran. 1998. gd T cells in host defense and epithelial cell biology. Clin. Immunol. Immunopathol. 86: 121-133. (Pubitemid 28081548)
16. Wilhelm, M., V. Kunzmann, S. Eckstein, P. Reimer, F. Weissinger, T. Ruediger, and H. P. Tony. 2003. gd T cells for immune therapy of patients with lymphoid malignancies. Blood 102: 200-206. (Pubitemid 36759655)
17. + gd T lymphocytes are cytotoxic to the MCF 7 breast carcinoma cell line and can be detected among the T cells that infiltrate breast tumors. Clin. Immunol. Immunopathol. 67: 17-24. (Pubitemid 23100060)
18. Schilbach, K. E., A. Geiselhart, J. T. Wessels, D. Niethammer, and R. Handgretinger. 2000. Human gd T lymphocytes exert natural and IL-2-induced cytotoxicity to neuroblastoma cells. J. Immunother. 23: 536-548.
19. Viey, E., G. Fromont, B. Escudier, Y. Morel, S. Da Rocha, S. Chouaib, and A. Caignard. 2005. Phosphostim-activated gd T cells kill autologous metastatic renal cell carcinoma. J. Immunol. 174: 1338-1347.
20. Corvaisier, M., A. Moreau-Aubry, E. Diez, J. Bennouna, J. F. Mosnier, E. Scotet, M. Bonneville, and F. Jotereau. 2005. Vγ9Vδ2 T cell response to colon carcinoma cells. J. Immunol. 175: 5481-5488. (Pubitemid 41456435)
21. + γδ-T cells mediate innate antitumor activity against human prostate cancer cells in vitro. J. Urol. 173: 1552-1556. (Pubitemid 40524770)
22. Gertner-Dardenne, J., C. Bonnafous, C. Bezombes, A. H. Capietto, V. Scaglione, S. Ingoure, D. Cendron, E. Gross, J. F. Lepage, A. Quillet-Mary, et al. 2009. Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies. Blood 113: 4875-4884.
23. Espinosa, E., C. Belmant, F. Pont, B. Luciani, R. Poupot, F. Romagné, H. Brailly, M. Bonneville, and J. J. Fournié. 2001. Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human gd T cells. J. Biol. Chem. 276: 18337-18344.
24. Alici, E., T. Sutlu, B. Björkstrand, M. Gilljam, B. Stellan, H. Nahi, H. C. Quezada, G. Gahrton, H. G. Ljunggren, and M. S. Dilber. 2008. Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components. Blood 111: 3155-3162.
25. Sicard, H., S. Ingoure, B. Luciani, C. Serraz, J. J. Fournié, M. Bonneville, J. Tiollier, and F. Romagné. 2005. In vivo immunomanipulation of Vγ9Vδ2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model. J. Immunol. 175: 5471-5480. (Pubitemid 41456434)
26. Gertner, J., A. Wiedemann, M. Poupot, and J. J. Fournié. 2007. Human gd T lymphocytes strip and kill tumor cells simultaneously. Immunol. Lett. 110: 42-53. (Pubitemid 46678226)
27. García, V. E., D. Jullien, M. Song, K. Uyemura, K. Shuai, C. T. Morita, and R. L. Modlin. 1998. IL-15 enhances the response of human gd T cells to non-peptide [correction of nonpetide] microbial antigens. J. Immunol. 160: 4322-4329. (Pubitemid 28217288)
28. + intestinal intraepithelial lymphocytes. J. Immunol. 162: 1896-1903.
29. Gertner-Dardenne, J., M. Poupot, B. Gray, and J. J. Fournié. 2007. Lipophilic fluorochrome trackers of membrane transfers between immune cells. Immunol. Invest. 36: 665-685.
30. Dieli, F., F. Poccia, M. Lipp, G. Sireci, N. Caccamo, C. Di Sano, and A. Salerno. 2003. Differentiation of effector/memory Vd2 T cells and migratory routes in lymph nodes or inflammatory sites. J. Exp. Med. 198: 391-397. (Pubitemid 36980610)
31. null mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100: 3175-3182. (Pubitemid 35217065)
32. Mariani, S., M. Muraro, F. Pantaleoni, F. Fiore, B. Nuschak, S. Peola, M. Foglietta, A. Palumbo, M. Coscia, B. Castella, et al. 2005. Effector gd T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma. Leukemia 19: 664-670. (Pubitemid 40521173)
33. Le Dieu, R., D. C. Taussig, A. G. Ramsay, R. Mitter, F. Miraki-Moud, R. Fatah, A. M. Lee, T. A. Lister, and J. G. Gribben. 2009. Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts. Blood 114: 3909-3916.
34. Bukowski, J. F., C. T. Morita, Y. Tanaka, B. R. Bloom, M. B. Brenner, and H. Band. 1995. Vγ2Vδ2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J. Immunol. 154: 998-1006.
35. Nedellec, S., C. Sabourin, M. Bonneville, and E. Scotet. 2010. NKG2D costimulates human Vγ9Vδ2 T cell antitumor cytotoxicity through protein kinase C u-dependent modulation of early TCR-induced calcium and transduction signals. J. Immunol. 185: 55-63.
36. Shibuya, A., D. Campbell, C. Hannum, H. Yssel, K. Franz-Bacon, T. McClanahan, T. Kitamura, J. Nicholl, G. R. Sutherland, L. L. Lanier, and J. H. Phillips. 1996. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 4: 573-581. (Pubitemid 26233311)
37. Bottino, C., R. Castriconi, D. Pende, P. Rivera, M. Nanni, B. Carnemolla, C. Cantoni, J. Grassi, S. Marcenaro, N. Reymond, et al. 2003. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J. Exp. Med. 198: 557-567. (Pubitemid 37040390)
38. Fuchs, A., and M. Colonna. 2006. The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance. Semin. Cancer Biol. 16: 359-366. (Pubitemid 44311500)
39. Pende, D., C. Bottino, R. Castriconi, C. Cantoni, S. Marcenaro, P. Rivera, G. M. Spaggiari, A. Dondero, B. Carnemolla, N. Reymond, et al. 2005. PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis. Mol. Immunol. 42: 463-469. (Pubitemid 39655955)
40. Pende, D., G. M. Spaggiari, S. Marcenaro, S. Martini, P. Rivera, A. Capobianco, M. Falco, E. Lanino, I. Pierri, R. Zambello, et al. 2005. Analysis of the receptorligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112). Blood 105: 2066-2073. (Pubitemid 40731793)
41. Carlsten, M., N. K. Björkström, H. Norell, Y. Bryceson, T. van Hall, B. C. Baumann, M. Hanson, K. Schedvins, R. Kiessling, H. G. Ljunggren, and K. J. Malmberg. 2007. DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells. Cancer Res. 67: 1317-1325.
42. Toutirais, O., F. Cabillic, G. Le Friec, S. Salot, P. Loyer, M. Le Gallo, M. Desille, C. T. de La Pintière, P. Daniel, F. Bouet, and V. Catros. 2009. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vγ9Vδ2 T cells. Eur. J. Immunol. 39: 1361-1368.
43. Costello, R. T., S. Sivori, E. Marcenaro, M. Lafage-Pochitaloff, M. J. Mozziconacci, D. Reviron, J. A. Gastaut, D. Pende, D. Olive, and A. Moretta. 2002. Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 99: 3661-3667. (Pubitemid 34534536)
44. Buggins, A. G., D. Milojkovic, M. J. Arno, N. C. Lea, G. J. Mufti, N. S. Thomas, and W. J. Hirst. 2001. Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-κB, c-Myc, and pRb pathways. J. Immunol. 167: 6021-6030. (Pubitemid 33062801)
45. Görgün, G., T. A. Holderried, D. Zahrieh, D. Neuberg, and J. G. Gribben. 2005. Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells. J. Clin. Invest. 115: 1797-1805. (Pubitemid 40979718)
46. Ramsay, A. G., A. J. Johnson, A. M. Lee, G. Gorgün, R. Le Dieu, W. Blum, J. C. Byrd, and J. G. Gribben. 2008. Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J. Clin. Invest. 118: 2427-2437. (Pubitemid 351949771)